View Post

Update on PALLAS triaI evaluating adjuvant palbociclib for early breast cancer

In Clinical Studies News by Barbara Jacoby

Source: ECOG-ACRIN Cancer Research Group From: The Austrian Breast & Colorectal Cancer Study Group (ABCSG), Alliance Foundation Trials (AFT), the Breast International Group (BIG), PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee (IDMC) for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study (PALLAS) trial determined that …